EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Platform-agnostic quantification for molecular interception of oral and esophageal malignancies: a global study addressing the diagnostic divide

Hung-Ming Lai, Hua-Ping Liu, Kaia Douglas, Keith Johnson, Xuanhua P Xie

JNCI Cancer Spectrum · 2026-11-02 · 10 (6)

DOI: 10.1093/jncics/pkag102 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Oral squamous cell carcinoma (OSCC) and esophageal squamous cell carcinoma are commonly diagnosed late because histopathology is subjective and robust molecular tools are lacking. Using interpretable machine learning, we aimed to develop an objective and platform-agnostic molecular measure of malignancy that could overcome the technical and geographic barriers associated with conventional genomic testing. Methods Using a discovery-to-generalization framework with 2541 samples, we developed and validated a single-sample transcriptomic scoring system called EsoralPrint. We feature-engineered 34 intrasample ordinal gene pairs (isoPairs) that capture consistent expression-order reversals between malignant and healthy states. The system was trained on oral tissues and externally validated across diverse global cohorts spanning the upper aerodigestive tract, technical platforms, and geographic regions. Independent single-cell RNA sequencing was used to provide post hoc mechanistic explainability. Results In the discovery cohort, EsoralPrint distinguished patients histologically graded as having low-risk hyperplasia who nonetheless progressed to cancer (log rank P < .001); we treated this result as exploratory pending independent confirmation. In external validations, EsoralPrint reached 95.0% accuracy and a 96.7% F1 score across OSCC cohorts (460 OSCC, 162 non-OSCC) and 91.6% accuracy and a 91.6% F1 score in esophageal tissue unseen during discovery and training (574 esophageal squamous cell carcinoma, 614 healthy mucosa samples). Further, a malignancy gradient reflecting field cancerization effects in resection boundaries was observed, and a transition zone (scores 0.25-0.75) was defined where molecular alterations preceded morphological changes. Conclusion EsoralPrint provides a platform-independent and quantitative complement to histological grading in oral and esophageal squamous malignancy, with the potential to give clinicians lead time for intervention. The tool can be accessed at https://github.com/aiphaqua/EsoralPrint.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →